CNSY

CERENOME, INC.

Company Overview

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

SectorHealthcare

IndustryMedical - Pharmaceuticals

Market Cap$12.4M

Last DividendNone

Employees28

CEOMarc H. Hedrick

Websitehttp://www.plustherapeutics.com

Valuation

Current Price$1.64

Fair Value?$000.00

Valuation?No valuation

Current PE ?0.08

Hist. PE ?N/Aⓘ

EPS (TTM) ?20.41

Forward EPS Growth ?—

Historical Growth ?54.10%

Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price?

EPS?

Revenue?

Equity?

Pro

Available on the Pro plan

Free Cash Flow?

Pro

Available on the Pro plan

Long Term Debt?

Pro

Available on the Pro plan

Net Profit?

Pro

Available on the Pro plan

Shares Outstanding?

Pro

Available on the Pro plan

Last updated: 10/23/2026, 11:01:36 PM